KRAS mutations are exceedingly common in pancreatic adenocarcinomas and colorectal cancers, while NRAS mutations are more common in melanomas, thyroid cancers, and leukemias (33, 34) (Figures 2A–C). Here, KRAS is linked to colorectal cancer.